Diffusion Pharmaceuticals Stock Price, News & Analysis
Company Description
Diffusion Pharmaceuticals (NASDAQ: DFFN) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $9.0M.
DFFN stock has gained 4.2% over the past year.
This page provides a comprehensive overview of DFFN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Diffusion Pharmaceuticals (DFFN) stock. Over the past 12 months, the stock has gained 4.2%. At a market capitalization of $9.0M, DFFN is classified as a micro-cap stock with approximately 2.0M shares outstanding.
Latest News
Diffusion Pharmaceuticals has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, clinical trial. View all DFFN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
DFFN Company Profile & Sector Positioning
Diffusion Pharmaceuticals (DFFN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing DFFN often look at related companies in the same sector, including (IMV), In8Bio, Inc. (INAB), KIORA PHARMACEUTICALS INC (KPRX), Calidi Biotherapeutics Inc (CLDI), and Genprex Inc (GNPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DFFN's relative position within its industry.